ArriVent BioPharma, Inc.
AVBPNasdaqCIK 1868279HealthcareFiscal year ends Dec 31
Reports and events: 52 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2606:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-118550 |
| 2026-10-1908:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-116736 |
| 2026-10-1306:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115161 |
| 2026-10-0818:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000931 |
| 2026-10-0608:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113898 |
| 2026-08-1216:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094902 |
| 2026-08-1216:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094869 |
| 2026-06-2216:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-076352 |
| 2026-05-1116:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-058706 |
| 2026-05-1116:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-058650 |
| 2026-05-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058638 |
| 2026-04-2816:08 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001104659-26-050337 |
| 2026-03-1717:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-029588 |
| 2026-03-0516:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-024127 |
| 2026-03-0516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-024112 |
| 2025-11-1008:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-108847 |
| 2025-11-1008:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-108839 |
| 2025-09-0908:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011954 |
| 2025-08-1319:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000764 |
| 2025-08-1108:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010975 |
| 2025-08-1108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010974 |
| 2025-07-2108:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-069169 |
| 2025-07-0217:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-065386 |
| 2025-06-2307:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061375 |
| 2025-06-2016:14 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-061165 |
| 2025-05-1209:35 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007276 |
| 2025-05-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007259 |
| 2025-04-2816:16 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001104659-25-040214 |
| 2025-04-2808:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-039799 |
| 2025-03-1317:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001558370-25-002912 |
| 2025-03-0307:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002002 |
| 2025-03-0307:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001999 |
| 2025-01-2219:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-004967 |
| 2024-11-1408:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015624 |
| 2024-11-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015622 |
| 2024-09-0912:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-098059 |
| 2024-08-1416:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012236 |
| 2024-08-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-012223 |
| 2024-07-0917:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-24-078587 |
| 2024-07-0917:03 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-078585 |
| 2024-06-0507:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-068503 |
| 2024-05-1616:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-062528 |
| 2024-05-0808:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007197 |
| 2024-05-0808:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007196 |
| 2024-04-2216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-049988 |
| 2024-03-2817:14 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-004280 |
| 2024-03-2816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-040532 |
| 2024-02-0516:42 ET | SC 13D | Ownership report, active investor | 0000947871-24-000091 |
| 2024-01-3016:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-008228 |
| 2024-01-2317:18 ET | S-1/A | Registration statement, amended | 0001104659-24-005933 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 06:02 ET. Listed shows no prices and gives no investment advice.